Solve with
Certainty.
At YPrime, we are committed to advancing science and health by simplifying the complexities of clinical trials. Our configurable clinical trial technology platform is designed to deliver speed, quality, and certainty. Offering 50% faster IRT startup times, 47% faster eCOA launch times, and quality standards that exceed the industry average by 50%, YPrime helps you solve with certainty. Schedule a demo to see how we can streamline your trials.
Meet Our Leadership Team
Meet the team that drives clinical trial innovation at YPrime, delivering solutions that empower better health outcomes.
Steve Begley,
Chief Compliance Officer
Steve Begley serves as Chief Compliance Officer at YPrime. Steve holds responsibility for corporate privacy strategy and policy and leads efforts to ensure company-wide privacy and data protection standards and compliance…
Steve Begley,
Chief Compliance Officer
Steve Begley serves as Chief Compliance Officer at YPrime. Steve holds responsibility for corporate privacy strategy and policy and leads efforts to ensure company-wide privacy and data protection standards and compliance. Additionally, he oversees the company’s global quality function, including quality control and assurance, regulatory compliance, process improvement, software development and delivery, and quality management systems. Steve provides the foundation and stability to deliver quality systems and products in a timely and effective manner across the entire organization.
Prior to joining YPrime in 2013, Steve managed global quality, compliance, and quality systems for Cenduit, ePharma Solutions, and Clarix/Phase Forward (now Oracle Corporation). He began his clinical trial career in data management, supporting studies at the University of Pennsylvania.
Steve received his undergraduate education from the Wharton School of Business at the University of Pennsylvania.
Shawn Blackburn,
Founder and Director
As President of YPrime Labs, Shawn Blackburn leads the Company’s efforts on future technology solutions in the eClinical space. With a background in systems architecture and information management…
Shawn Blackburn,
Founder and Director, YPrime
As the Founder and Director of YPrime, Shawn Blackburn leads the Company’s efforts on future technology solutions in the eClinical space. With a background in systems architecture and information management, Shawn has built a reputation for helping companies discover insights about future opportunities by bringing together siloed information in a meaningful context to support strategic decision-making.
Since co-founding YPrime in 2006, Shawn has led the Company’s growth from a two-person consulting firm to a global organization that focuses on evolving technologies to help accelerate development timelines, simplify process complexity, and improve data quality across the clinical development continuum.
Prior to YPrime, Shawn had a long career as a technology consultant for Cephalon and Parexel. While at Cephalon, he was instrumental in the company’s development of applications to improve clinical trial workflow and provide deeper visibility into clinical trial performance.
Lindsay Daniel,
Chief Human Resources Officer
As Chief Human Resources Officer, Lindsay Daniel partners with the executive leadership team to craft and execute the global HR strategy, leading people-focused initiatives and cultivating a high-performing, engaged workforce…
Lindsay Daniel,
Chief Human Resources Officer
Lindsay Daniel serves as Chief Human Resources Officer at YPrime. In this role, she partners with the executive leadership team to craft and execute the global HR strategy, leading people-focused initiatives and cultivating a high-performing, engaged workforce.
Lindsay also oversees all HR functions, ensuring compliance and driving talent acquisition, development, and retention programs.
Lindsay brings close to 15 years of experience to YPrime. Most recently, she served as Senior Vice President of Human Resources at Macquarie Asset Management (MAM), where she provided counsel and delivery of talent management, employee relations, organizational design and change management, compensation/benefits, and resource planning.
Lindsay holds a Bachelor of Arts in Psychology from Dickinson College.
Mohan Ganesan,
Chief Financial Officer
As Chief Financial Officer, Mohan Ganesan provides financial and strategic guidance to the Company and partners with investors and the Executive Leadership Team to drive investments appropriately…
Mohan Ganesan,
Chief Financial Officer
As Chief Financial Officer, Mohan Ganesan provides financial and strategic guidance to the Company and partners with investors and the Executive Leadership Team to drive investments appropriately. With responsibility for Finance, Accounting, and Business Operations functions, Mohan provides financial oversight and leads the development of standardized business metrics.
Mohan brings more than 20 years of broad finance leadership expertise in the life sciences industry with diverse experience at pharmaceutical, biotech, and healthcare companies. Most recently, Mohan served as Chief Financial Officer of Amplity Health, a leading contract commercial services provider to pharmaceutical and biotech companies. At Amplity, he led the carve-out from Publicis Groupe and built the infrastructure of an independent private healthcare company. Prior to this, Mohan served as Chief Financial Officer of Publicis Healthcare Solutions (PHS), a division of Publicis Groupe. At PHS, Mohan diversified the customer base, integrated two critical acquisitions to drive growth, and led the sale of the company to private equity.
Previously, Mohan served as Vice President, Finance at Epocrates, a healthcare information technology company, where he built the Financial Analysis team and played an integral role in the acquisition and post-merger integration of Epocrates by Athenahealth. His early healthcare experience includes positions at Amicus Therapeutics, a rare disease biotech, and at Pfizer, where he held a broad range of finance roles of increasing responsibility. Mohan started his career as an engineer in the chemical industry before transitioning to healthcare finance.
Mohan has an MBA in Finance from the University of Chicago Booth School of Business, an MS in Chemical Engineering from Georgia Tech, and a BS in Chemical Engineering from the Indian Institute of Technology.
Mike Hughes,
Chief Product Officer
As Chief Product Officer, Mike Hughes leads engineering, development and product management functions for YPrime’s products and service. For more than a decade, Mike has been actively involved in the evolution of…
Mike Hughes,
Chief Product Officer
As Chief Product Officer, Mike Hughes leads engineering, development and product management functions for YPrime’s products and services.
For more than a decade, Mike has been actively involved in the evolution of mobile health solutions for clinical outcome assessments. Prior to joining YPrime in 2015, he served in multiple positions of increasing responsibility at CRF Health. Mike began as an application specialist in 2006, served in project management functions. As Director of Project Delivery, he oversaw the company’s project management and software implementation functions.
Mike began his career as an application developer for Exact Software, a provider of manufacturing resource planning software for the apparel industry.
Ian Lennox,
Executive Chairman
Ian Lennox is a seasoned biopharmaceutical executive and strategic investor with over two decades of leadership experience driving growth and innovation across the life sciences ecosystem. As Executive Chairman of YPrime, he leads the company in fulfilling its mission…
Ian Lennox,
Executive Chairman
Ian Lennox is a seasoned biopharmaceutical executive and strategic investor with over two decades of leadership experience driving growth and innovation across the life sciences ecosystem. As Executive Chairman of YPrime, he leads the company in fulfilling its mission of advancing science and health by simplifying clinical trials.
Lennox has an exceptional track record as a CEO, having led Drug Royalty (DRI), MDS Pharma Services, and Ricerca LLC to significant growth and market success. As an investor and director, Lennox has successfully guided Celerion, Aptiv (Icon), LakePharma (Curia), and Bracket (now Signant) through critical growth phases. He is a current investor and director of Evidation Health (RWD) and CHS (Hospital Supplies).
Lennox pairs deep life sciences expertise with a history of building market-defining companies. Under his leadership, YPrime is redefining clinical trial technology —bringing greater speed, precision, and scalability to sponsors and CROs globally.
Mark Maietta,
President
As President of YPrime, Mark Maietta provides executive leadership and directs the Company’s commercial strategy. With oversight of the sales, business development and commercial operations functions…
Mark Maietta,
President
As President of YPrime, Mark Maietta provides executive leadership and directs the Company’s commercial strategy. With oversight of the sales, business development and commercial operations functions, he is responsible for ensuring the Company’s commercial objectives and service delivery align and evolve with customer needs.
Mark is a growth catalyst and is a specialist in driving value globally. He brings more than 25 years of leadership experience within the life sciences and technology sectors. Most recently, Mark served as Chief Commercial Officer for Clariness, a provider of digital patient recruitment and engagement solutions. There, he built and led global commercial infrastructure to drive revenue and position the company as a global leader. Prior to Clariness, Mark was Chief Business Officer at AdviseClinical, a clinical strategic advisory and staffing organization.
During his tenure as Senior Vice President of Business Development and Marketing for CRF Health, Mark redesigned business development and marketing practices and helped to create a global industry leader. Early career positions with OPTUMInsight (now part of United Health Group), Pfizer, and Novartis Pharmaceuticals included sales management and field sales positions.
Mark has an MBA from Binghamton University and a BS in Marketing from Ithaca College.
Grazia Mohren,
Vice President, Marketing
As Vice President of Marketing, Grazia Mohren leads the development and execution of comprehensive marketing strategies to drive growth for YPrime. With experience in both commercial and clinical…
Grazia Mohren,
Vice President, Marketing
As Vice President of Marketing, Grazia Mohren leads the development and execution of comprehensive marketing strategies to drive growth for YPrime. With experience in both the commercial and clinical aspects of life sciences, Grazia has developed deep expertise in brand development, demand generation, digital marketing, and strategic sales initiatives. Her career spans roles at tech companies, emerging startups, and CROs, including IQVIA, where she led marketing for multiple technology launches with a focus on high-touch customer-centric campaigns. Grazia’s passion for leveraging technology and partnerships to advance business outcomes has helped improve business performance and brand recognition through impactful, results-driven marketing strategies.
David K. Wallace,
Chief Technology Officer
As Chief Technology Officer, David Wallace is responsible for the development of YPrime’s technology solutions for its customers. He leads the Infrastructure, Security, and DevOps teams…
David K. Wallace,
Chief Technology Officer
As Chief Technology Officer, David Wallace is responsible for the development of YPrime’s technology solutions for its customers. He leads the Infrastructure, Security and DevOps teams that enable secure, scalable, and reliable services to the business. Utilizing a proven agile methodology, David ensures that YPrime is consistently focused on delivering new and refined capabilities of its solutions to support its clients.
David brings almost 30 years of broad technology experience to YPrime. Most recently, he was Chief Technology Officer of Circonus, a Full Stack Performance Monitoring and Observability Platform serving the largest infrastructure deployments in the world. David led the effort in building and scaling their engineering organization and improving their Software Development Lifecycle (SDLC).
For 10 years prior to Circonus, David was the Chief Technology Officer of Greenphire, the industry leader in clinical trial payments solutions, where he was responsible for engineering, SDLC, testing, infrastructure, and security. David helped grow the company from 15 to 350 people, expanded existing products globally, and introduced multiple new products to market – all while building an engineering team that enabled consistent, reliable delivery of capabilities for the business and its customers.
David previously spent multiple years at iPipeline, the leading provider of cloud-based solutions for the life insurance industry. As Director of Information Technology, he led the effort in building out its infrastructure and security from the startup phase to being the market leader in its solutions.
David resides in Chester Springs, PA with his wife and children. During his free time, you may find him planning his travels to new places around the world, playing golf, or hiking some of the beautiful trails of Chester County.
Our Mission: Advancing Science and Health by Simplifying Clinical Trials
YPrime’s Commitment to Sustainability
YPrime has achieved a top-tier EcoVadis rating, placing it in the top 35% of more than 157,000 companies assessed globally. This prestigious medal highlights YPrime’s dedication to enhancing its Environmental, Social, and Governance (ESG) performance. The company enforces a Sustainable Procurement Policy, implements global device recycling programs, and is developing a carbon management plan aligned with the Paris Agreement targets. These initiatives underscore YPrime’s commitment to ethical, inclusive, and responsible clinical research.
YPrime’s Commitment to Ethical Labor Practices and Inclusion
At YPrime, we are unwavering in our commitment to upholding the highest standards of ethical labor practices and fostering a culture of equity and inclusivity. Our principles are embedded in everything we do, ensuring that we contribute to a fair and equitable society. We are committed to:
Eliminating Child and Forced Labor
YPrime has a zero-tolerance policy for child labor, forced labor, and modern slavery in any form. We comply with all applicable laws and regulations, including the United Nations Guiding Principles on Business and Human Rights, and hold our suppliers and partners to the same rigorous standards. Our practices include:
If any violations are identified, YPrime will take immediate and appropriate action, including terminating relationships with non-compliant suppliers or partners.
Anti-Modern Slavery
We recognize the global issue of modern slavery and are committed to its eradication. YPrime actively works to prevent and address instances of modern slavery through:
Join Our Team
Careers at YPrime offer the chance to be part of a dynamic team committed to innovation and excellence in clinical trials. Join us to help shape the future of health and science.
Looking for Tech Support?
If you need assistance with our technology, our dedicated team is ready to help.